Table 2 Treatment details
Variable | Category | Count | % |
|---|---|---|---|
RT dose received | <60Gy | 12 | 22.2 |
60Gy | 42 | 77.8 | |
RT type | High dose palliative | 10 | 18.5 |
Radical | 44 | 81.5 | |
RT breaks | No | 54 | 100 |
Yes | 0 | 0 | |
Chemo regimen | Carboplatin + paclitaxel + gefitinib | 4 | 7.4 |
Carboplatin + paclitaxel weekly | 20 | 37 | |
Carboplatin weekly | 3 | 5.6 | |
Carboplatin weeks 1 and 6 | 17 | 31.5 | |
Gemcitabine weekly | 8 | 14.8 | |
Vinorelbine + Cisplatin weekly | 2 | 3.7 | |
Neoadjuvant chemo | No | 52 | 96.3 |
Yesa | 2 | 3.7 | |
NGPEG pre CRT | No | 54 | 100 |
Yes | 0 | 0 | |
NGPEG during CRT | No | 53 | 98.1 |
Yes | 1 | 1.9 | |
Steroids pretreatment | No | 49 | 90.7 |
Yes | 5 | 9.3 | |
Steroids during | No | 27 | 50 |
Yes | 27 | 50 | |
PPI pre | No | 45 | 83.3 |
Yes | 9 | 16.7 | |
PPI during | No | 34 | 63 |
Yes | 20 | 37 | |
H2Antag pre CRT | No | 52 | 96.3 |
Yes | 2 | 3.7 | |
H2Antag during CRT | No | 46 | 85.2 |
Yes | 8 | 14.8 | |
Local analgesia | No | 17 | 31.5 |
Yes | 37 | 68.5 | |
Type local analgesia | Aluminium hydroxide and oxethazaine (Mucaine) | 12 | 32.4 |
Lignocaine viscous and Mucaine | 22 | 59.5 | |
Lignocaine viscous only | 3 | 8.1 | |
Systemic analgesia | No | 18 | 33.3 |
Yes | 36 | 66.7 | |
Type sys analgesia | non-opioid | 8 | 22.2 |
strong opioid | 21 | 58.3 | |
weak opioid | 7 | 19.4 |